Prostate Cancer Forecast in 18 Major Markets 2016-2026 - Analysis, Technologies, Trends & Forecasts - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Prostate Cancer Forecast in 18 Major Markets 2016-2026" report to their offering.

This report provides the current incident population for Prostate Cancer across 18 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil, Japan, Argentina, Australia, Canada, India, Mexico, Russian Federation, Saudi Arabia, South Africa, Turkey and China) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team, several of the main symptoms and co-morbidities of Prostate Cancer have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies.

Reason to buy:

  • Able to quantify patient populations in global Prostate Cancer's market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the incidence of the subdivided types of Prostate Cancer and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Prostate Cancer's incident population.

Report Structure:

List of Tables and Figures

Introduction

Cause of the Disease

Risk Factors & Prevention

Diagnosis of the Disease

Variation by Geography/Ethnicity

Disease Prognosis & Clinical Course

Key Co-morbid Conditions/Features Associated with the Disease

Methodology for Quantification of Patient Numbers

Top-Line Incidence for Prostate Cancer

Features of Prostate Cancer Patients

Prostate Cancer by Stage

Treated Prostate Cancer Patients by Hormonal Status

Abbreviations used in the Report

Other Black Swan Analysis Publications

Online Pricing Data and Platforms

References

Appendix

For more information about this report visit http://www.researchandmarkets.com/research/qbc7k8/prostate_cancer

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Prostate Cancer Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Prostate Cancer Drugs